Dr Riyaz Shah

MB, BS, FRCP, PhD

Medical oncologist

Spoken languages

English

Special clinical interests in thoracic, gastrointestinal and acute oncology.

Dr Shah trained at Guy’s and St Thomas’ Hospitals between 1988 and 1994, obtaining a First Class Honours Intercalated BSc in Experimental Pathology.

He undertook medical training at The London Chest Hospital, Hammersmith Hospital, University College London, Guy’s Hospital and The Royal Marsden. He obtained Membership of the Royal College of Physicians of London in 1997.

Dr Shah was awarded a Clinical Research Fellowship by The Imperial Cancer Research Fund undertaking a period of research looking at abnormal genes in pancreatic cancer and utilising this to try and develop a cancer specific viral gene therapy. This work led to the award of a PhD.

Dr Shah subsequently trained to become a specialist in Medical Oncology at The Royal Marsden Hospital and was awarded an ASCO Foundation Merit Award in 2005. He was appointed Consultant Medical Oncologist at the Kent Oncology Centre in 2006.

Dr Shah provides specialist services in cancer systemic therapy to three acute NHS Trusts. He also provides services as a private medical oncologist at several hospitals.

He is involved in training future medical oncologists and has an extensive role in clinical research. He has served on the NCRI Lung Group, acted as chairman of the Kent Lung Network Lead and continues to be the lead for research at his cancer centre.

Dr Shah is heavily involved in clinical research. He acts as principal investigator on many trials in his centre and has been a major champion in the introduction of immunotherapy into routine clinical practice within Kent.

He has published widely and regularly speaks both nationally and internationally on cancer issues.

Research interests

Dr Shah is an active clinical researcher and acts as a principal investigator (PI) on a range of clinical trials examining novel drugs in cancer. He is the Research Lead for the Kent Oncology Centre and is a member of the National Cancer Research Institute (NCRI) Lung Clinical Studies Group and advanced disease subgroup. He chairs the Kent Lung Tumour Site Specific Group on behalf of the Kent Cancer Collaborative and has published widely in peer reviewed journals and international meetings.

NHS Hospital / current post(s)

Consultant Medical Oncologist, Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust

Year qualified

1994

Treatments

  • Chemotherapy

Specialties

  • Thoracic and gastrointestinal malignancies

Professional memberships

  • Fellow of the Royal College of Physicians (FRCP)

Awards received

  • Awarded an American Society of Clinical Oncology (ASCO) Foundation Merit Award in 2005